Fundraising FoxQUEoncology Healthier menopause treatments
Atlanta, US · 2 known investors
Find your way into QUEoncology Healthier menopause treatments
Sign up to see every warm intro you have to QUEoncology Healthier menopause treatments
- Paths you didn't know you had: your email and LinkedIn already hold routes to the QUEoncology Healthier menopause treatments team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
QUE Oncology develops Q-122, a non-hormonal therapeutic candidate in clinical development for treating vasomotor symptoms in postmenopausal women and cancer patients on hormone therapy. The company was formed as a joint venture between Emory University and University of Queensland's commercialization entity.
Investors · 2
Frequently asked questions
- What does QUEoncology Healthier menopause treatments do?
- QUE Oncology develops Q-122, a non-hormonal therapeutic candidate in clinical development for treating vasomotor symptoms in postmenopausal women and cancer patients on hormone therapy. The company was formed as a joint venture between Emory University and University of Queensland's commercialization entity.
- Who are QUEoncology Healthier menopause treatments's investors?
- QUEoncology Healthier menopause treatments's investors include Brandon BioCatalyst, Stoic VC.
- Where is QUEoncology Healthier menopause treatments headquartered?
- QUEoncology Healthier menopause treatments is headquartered in Atlanta, US.